Genomic Cancer Panel and Profiling Market Set to Reach $26.59 Billion by 2033, Fueled by Advances in Precision Medicine
27 févr. 2024 11h44 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application,...
Global Precision Oncology Market Report 2023: Technological Innovations Propel Growth Opportunities
30 janv. 2024 11h28 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Precision Oncology Market Trends and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The emergence of...
Oncology Precision Medicine Market Projected to Surpass $123 Billion by 2028, Driven by Technological Innovations and Personalized Treatment Approaches
29 janv. 2024 06h49 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global Aseptic Sampling Industry Research Report 2024-2030: Downstream Processing Held the Largest Market Revenue Share in 2023 and is Expected to Register the Fastest Growth to 2030
12 janv. 2024 10h28 HE
|
Research and Markets
Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The "Global Aseptic Sampling Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The global...
Global Single-cell Analysis Technology Market Report 2023: Technological Advancements Propel New Diagnostic and Therapeutic Opportunities
05 janv. 2024 06h33 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Single-cell Analysis: Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study identifies the...
Global Genomic Cancer Panel & Profiling Market Report 2023-2033: Genomic Cancer Panels Set to Disrupt Traditional Screening
20 déc. 2023 11h28 HE
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application,...
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
01 nov. 2023 16h05 HE
|
Prelude Therapeutics, Inc.; AbCellera
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
ITM Reports on Participation at 3rd ICPO Forum for Theranostics in Precision Oncology and Announces Support for ICPO Academy for Theranostics
24 oct. 2023 08h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, October 24, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today reported on its participation at the 3rd International...
Modifi Bio Raises Additional $4.3 Million in Seed Funding
16 oct. 2023 07h00 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in DNA modification as a novel approach to target cancer, today announced the closing of $4.3 million in a second...
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
14 oct. 2023 12h30 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage precision oncology company, announces multiple clinical...